Official data records myocarditis and cardiac failure after man’s second Pfizer dose
September 8, 2026
Summarised by Centrist
An official Medsafe line listing records an adverse-event report involving a New Zealand man aged 30 to 39 after his second Pfizer dose. The reported terms include myocarditis, cardiac failure, chest discomfort, fever, nausea and other symptoms.
The case was first reported in 2021.
Medsafe warns that adverse-event reports record events occurring after vaccination, not necessarily because of it. Reports can be incomplete, and individual entries cannot by themselves establish incidence or causation.
There is, however, a recognised causal association between mRNA vaccines and rare myocarditis and pericarditis, particularly in younger males and more often after a second dose.
That established risk makes proper investigation of individual cardiac reports important. But “cardiac failure” is not automatically myocarditis, and temporal proximity alone is not a diagnosis.
Read more at X | Medsafe case listing | Medsafe guidance
Community Discussion
Comment Policy